Your browser doesn't support javascript.
The Impact of COVID-19 on Brain Stimulation Therapy.
Coffey, Michael Justin; Kerns, Suzanne; Sanghani, Sohag; Wachtel, Lee.
  • Coffey MJ; Geisinger Health System, 100 N Academy Ave, Danville, PA 17822, USA. Electronic address: jcoffey1@geisinger.edu.
  • Kerns S; Medical University of South Carolina, Charleston, SC, USA.
  • Sanghani S; Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
  • Wachtel L; Kennedy Krieger Institute, Baltimore, MD, USA.
Psychiatr Clin North Am ; 45(1): 123-131, 2022 03.
Article in English | MEDLINE | ID: covidwho-1517438
ABSTRACT
Among the far-reaching effects of the COVID-19 pandemic has been restricted access to safe and effective forms of psychiatric treatment. Focusing on electroconvulsive therapy and transcranial magnetic stimulation, we review the pandemic's impact on brain stimulation therapy by asking 3 fundamental questions-Where have we been? How are we doing? And where are we going?
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Electroconvulsive Therapy / COVID-19 Type of study: Experimental Studies Limits: Humans Language: English Journal: Psychiatr Clin North Am Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Electroconvulsive Therapy / COVID-19 Type of study: Experimental Studies Limits: Humans Language: English Journal: Psychiatr Clin North Am Year: 2022 Document Type: Article